Specific targeting of IL-1β activity to CD8+ T cells allows for safe use as a vaccine adjuvant
Bram Van Den Eeckhout(Ghent University), Sarah Gerlo(University College Ghent)
Cited by 27
Related Papers
On the whereabouts of SARS-CoV-2 in the human body: A systematic review
|PLoS Pathogens|2020|231
Organ-specific genome diversity of replication-competent SARS-CoV-2
|Nature Communications|2021|77
Integrative Assessment of Total and Intact HIV-1 Reservoir by a 5-Region Multiplexed Rainbow DNA Digital PCR Assay
|Clinical Chemistry|2024|15
β-Agonists Selectively Modulate Proinflammatory Gene Expression in Skeletal Muscle Cells via Non-Canonical Nuclear Crosstalk Mechanisms
|PLoS ONE|2014|9
In-depth Analysis of the HIV Reservoir Confirms Effectiveness and Safety of Dolutegravir/Lamivudine in a Phase 4 Randomized Controlled Switch Trial (RUMBA)
|The Journal of Infectious Diseases|2024|8